Market analysis reveals AbbVie (NYSE:ABBV)AbbVie is a drug company with a strong exposure to immunology and oncology.
Market analysis shows company’s top drug, Humira, represents close to half of the company’s current fits, given current economic conditions. The company was spun off from Abbott in early 2013.
The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health. Furthermore, AbbVie(NYSE:ABBV)Quote (something worth watching).
However, Last-: 7:40 PM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg. On the other hand, 649MMkt Cap335. 263BDay Range- - -52 Wk Range163 (fascinating analysis).
On the other hand, 660Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialImmix Biopharma (NASDAQ:IMMX)Immix Biopharma Inc is a clinical-stage biopharmaceutical company Tissue-Specific Therapeutics in oncology and inflammation.
This analysis suggests that tells us that s duct candidate drug candidates to circulate in the blood, exit through tumor blood vessels and simultaneously attack all components of the TME.
Moreover, Immix Biopharma(NASDAQ:IMMX)Quote. Moreover, Last-: 9:10 AM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg. Nevertheless, 571KMkt Cap82 (an important development).
Moreover, 238MDay Range- - -52 Wk Range1.
200Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialJohnson & Johnson (NYSE:JNJ)Johnson & Johnson is the world’s largest and most diverse healthcare firm.
Nevertheless, Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer.
The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm.
Moreover, The drug division focuses on the ing therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases.
However, The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas.
The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health.
Additionally, Geographically, just over half of total sales are generated in the United States. On the other hand, Johnson & Johnson(NYSE:JNJ)Quote.
Last-: 7:57 PM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg. At the same time, 283MMkt Cap406. 626BDay Range- - -52 Wk Range140.
990Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialPfizer (NYSE:PFE)Founded in 1849 and headquartered in New York, New York, Pfizer Inc.
Moreover, Discovers, develops, manufactures, distributes and sells biopharmaceutical ducts worldwide, offering medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, women’s health, infectious diseases with unmet medical needs, COVID-19 prevention and treatment along with potential future mRNA and antiviral ducts under the Comirnaty and Paxlovid brands.
Pfizer also vides medicines and vaccines in various therapeutic areas, amyloidosis, hemophilia, endocrine diseases, and sickle cell disease, sterile injectable and anti-infective medicines and biologics, small molecules, immunotherapies and biosimilars.
Furthermore, Pfizer also maintains collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US Inc. Additionally, , Myovant Sciences Ltd.
However, , Merck KGaA, Valneva SE, BioN SE and Arvinas, Inc. Furthermore, Pfizer(NYSE:PFE)Quote. Last-: 7:14 AM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg. 810MMkt Cap143.
Nevertheless, 840BDay Range- - -52 Wk Range20 (noteworthy indeed).
At the same time, 540Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialuniQure (NASDAQ:QURE)uniQure NV is a gene therapy company (this bears monitoring).
This analysis suggests that develops treatment and platforms for patients suffering from genetic and other devastating diseases.
On the other hand, Its ducts and services are focused on hemophilia, Huntington’s disease, and cardiovascular diseases, given the current landscape.
Moreover, Market analysis shows company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
UniQure(NASDAQ:QURE)Quote. Last-: 7:10 AM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg. 467MMkt Cap837 (an important development).
In contrast, 652MDay Range- - -52 Wk Range4, given current economic conditions.
Additionally, 180Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialKiora Pharmaceuticals (NASDAQ:KPRX)Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company.
This analysis suggests that focuses on and commercializing ducts for treating diseases and disorders of the eye. The ducts pipeline of the company includes KIO-101, KIO-201, KIO-301, and KIO-102.
However, Kiora Pharmaceuticals(NASDAQ:KPRX)Quote. Last-: 7:11 AM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg. Additionally, 020K / 451. 608KMkt Cap9.
Nevertheless, 406MDay Range- - -52 Wk Range2.
800Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga Trial ()Inozyme Pharma Inc is a rare disease biopharmaceutical company novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton (this bears monitoring).
The company is focused on a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies.
Furthermore, Its duct candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion tein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies.
()Open-Close-Vol / Avg.
- / -Mkt Cap-Day Range- - -52 Wk Range- - -Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialQuoin Pharmaceuticals (NASDAQ:QNRX)Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on and commercializing therapeutic ducts that treat rare and orphan diseases (an important development).
Moreover, Its pipeline comprises three ducts that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Quoin Pharmaceuticals(NASDAQ:QNRX)Quote, in light of current trends. Last-: Jul 18, 4:19 AM (Delayed 15-Minutes)Get Real Time HereOpen-Close-Vol / Avg, given the current landscape. 610KMkt Cap5.
However, At the same time, 058MDay Range- - -52 Wk Range5, in this volatile climate.
On the other hand, Meanwhile, 950Trade with PublicSellCompare Broketart Your Free 14-Day Benzinga TrialBio stocks are in the eye of the storm as the world recovers from the global pandemic, in today's market environment.
Government institutions and fessional traders are banking on bio stocks to continually develop a vaccine and boosters that can eradicate COVID-19.
On the other hand, Tilt your stock portfolio toward bio companies now and you could stand to make substantial fits in the near future.
You can also find cost-effective stocks under $20 to trade daily on the stock exchange. Stock MoversTickerCompanyClose▲▼±%Avg, considering recent developments.
Vol▲▼Buy StockNo ResultsGet in real-timeTickerCompanyClose▲▼±%Avg.
Vol▲▼Buy StockNo ResultsGet in real-timeSession: Jul 22, 2025 4:00PM EDT - Jul 23, 2025 3:59PM EDTTable of ContentsOverview: Bio StocksBest Online Brokers for Bio StockFeatures to Look for in Bio StockSee All 5 ItemsOverview: Bio StocksBio companies are a subsector of healthcare stocks that primarily focus on new drugs and treatments for medical conditions, diseases and viruses, considering recent developments.
However, The stock value and growth potential of a bio firm depend on the type of diseases it treats.
Nevertheless, This might also include the re that the firm does as it supports other companies, diseases or treatments.
For instance, a bio firm working on breast cancer treatments, which has nearly 300,000 new cases in the U.
Each year, might be more valuable than a company that is drugs for Ogilvie's Syndrome, a rare disease that only affects 1%–3% of the population (which is quite significant).
Every new drug developed by bio firms has to be submitted to the Food and Drug Association (FDA) for apval. Meanwhile, Medical companies spend years a new drug but may fail to get it apved by the FDA.
Some of these drugs will never hit the shelf of pharmaceuticals even after countless clinical trials.
On the other hand, if a bio company gets a new drug sanctioned by the FDA and the demand is high, the stock value can double or even triple overnight (fascinating analysis).
Additionally, Best Online Brokers for Bio StockAn online broker can help you trade bio stocks with speed and precision.
You can gain access to fessional-level trading tools such as stock screens by opening an account on these platforms (this bears monitoring), in this volatile climate.
Furthermore, Online brokers let you apply custom s such as setting a price range to narrow down stocks under $10 within minutes.
On the other hand, Explore these online brokers to get started today (which is quite significant).
Claim Exclusive OffersInteractive Brokers ReviewBest For:Active and Global TradersVIEW S & CONS:Securely through Interactive Brokers’ websiteGet Started with Interactive BrokersPlus500 ReviewBest For:Leveraged TradingVIEW S & CONS:securely through Plus500 Yield's websiteGet Started with Plus500public.
Com ReviewBest For:Trading IdeasVIEW S & CONS:securely through public. Nevertheless, Meanwhile, Com's websiteGet Started with public.
Furthermore, ComRobinhood ReviewBest For:BeginnersVIEW S & CONS:securely through Robinhood's websiteGet Started with RobinhoodTradeZero ReviewBest For:Active Short Sellers With Modest CapitalVIEW S & CONS:securely through TradeZero's websiteGet Started with TradeZeroFeatures to Look for in Bio StockEarnings per : You can determine the fitability of a company by its earnings per (EPS) (this bears monitoring).
It's calculated by dividing the net income of the company by the total number of its outstanding s (an important development).
Price-earnings ratio: The price-earnings ratio (P/E ratio) is calculated by dividing the current stock price by its EPS. Based on the P/E ratio, you can assess if a stock is undervalued or overvalued.
The lower the P/E ratio of the stock, the better an investment it is, considering recent developments. However, Generally, penny stocks under $5 have the lowest P/E ratios.
On the other hand, Medical innovation: Bio firms can spend years conducting clinical trials to test a new drug, amid market uncertainty.
Keep a constant watch on any news regarding medical breakthroughs and FDA apvals to make the most of your trade.
Relevancy: Apart from medical innovation, you need to invest in stocks that are relevant—and continue to remain relevant.
Moreover, Re specifically what these companies do, drugs they’re working on, therapies that they have created and how those ideas remain in the headlines, even if the company is rather old, in today's market environment.
Be Patient for Better fitsAdvanced medical nology has led to longer and more fulfilling s.
An investment in bio stocks involves longer buy-and-hold periods, but if you are patient with your trades, you can strike gold when you least expect it.
Remember, the bio industry can shift very quickly, during the COVID-19 pandemic.
Be patient, do the re and don’t be afraid to exit positions that might not work well for you, in light of current trends.
However, Every industry shifts at different times, and that’s why patience is so critical for investors. Frequently Asked QuestionsQWhat is bio.
ABio is the area of biology that uses living cesses, organisms and systems to manufacture ducts or nologies (which is quite significant).
Usually these ducts are int to imve human life (which is quite significant). However, QIs bio worth in (something worth watching). ABio can be a great long-term investment.
QWhat small bio company did Jeff Bezos invest in. AJeff Bezos invested in Altos Labs, which is a startup that concentrates on extending the human life, given current economic conditions.
Continue reading: BEST PHARMACEUTICAL STOCKSBEST BIO PENNY STOCKS (this bears monitoring), in today's financial world.